SCND · Scientific Industries Inc · Insider Trading

On 2/17/26 Registrant was awarded stock options in lieu of cash fees. Vesting 1 Year - 1/12th per month.

Vesting is based on 4 year cliff from date of option grant.

Options granted to Registrant in lieu of cash fees. Vesting 1 year - 1/12th per month.

Options granted to Registrant in lieu of cash compensation. Vesting is 1 year - 1/12th per month.

Vesting is based on 4 year cliff from date of option grant.

Options granted to Registrant in lieu of salary. Vesting 1 year - 1/12th per month.

On 2/17/26 Registrant was awarded stock options in lieu of cash fees. Vesting 1 Year - 1/12th per month.

On August 20, 2025, 30,000 warrants for 30,000 shares of the Company's common stock were exercised at $1.00 per share.

On August 20, 2025 15,000 warrants for 15,000 shares of the Company's common stock were exercised at $1.00 per share.

On August 20, 2025, 10,000 warrants for 10,000 shares of the Company's Common Stock were exercised at $1.00 per share.

1/4 of the option shares vest one year from issue date, the balance of the shares vest in a series of thirty six (36) equal monthly installments measured from the first anniversary date of the issue date.

1/4 of the option shares vest one year from issue date, the balance of the shares vest in a series of thirty six (36) equal monthly installments measured from the first anniversary date of the issue date.

On April 18, 2025 Registrant purchased from Scientific Industries, Inc. (the "Issuer") for an aggregate purchase price of $15,000, 15,000 shares of Common Stock and warrants to acquire 15,000 shares of Common Stock at an exercise price of $1.00 per share.

On April 18, 2025, 21 April Fund, Ltd. and 21 April Fund, LP agreed to purchase from Scientific Industries Inc. (the "Issuer"), for an aggregate purchase price of $250,000, 250,000 shares of Common Stock and warrants to acquire 250,000 shares of Common Stock at an exercise price of $1.00 per share.

This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.

On April 18, 2025 Registrant purchased from Scientific Industries, Inc. (the "Issuer") for an aggregate purchase price of $10,000, 10,000 shares of Common Stock and warrants to acquire 10,000 shares of Common Stock at an exercise price of $1.00 per share.

On April 18, 2025, 21 April Fund, Ltd. and 21 April Fund, LP agreed to purchase from Scientific Industries Inc. (the "Issuer"), for an aggregate purchase price of $250,000, 250,000 shares of Common Stock and warrants to acquire 250,000 shares of Common Stock at an exercise price of $1.00 per share.

This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.

On April 18, 2025 Registrant purchased from Scientific Industries, Inc. (the "Issuer") for an aggregate purchase price of $35,000, 35,000 shares of Common Stock and warrants to acquire 35,000 shares of Common Stock at an exercise price of $1.00 per share.

Includes 128,082 shares of Common Stock, 286,134 Options to Purchase Common Stock, and 65,556 Warrants to Purchase Common Stock.

Options vest in three successive equal installments from 5/17/24 as to 1/3 on each of the first, second, and third anniversaries.

On May 17, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid part of his fees in lieu of cash compensation. These options vest in twelve monthly installments commencing on May 17, 2024 through May 17, 2025.

On April 1, 2024, the Reporting Person and the Issuer entered into an agreement whereby the Reporting Person elected to be paid part of her salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025.

On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's Board of Director fees in options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024.

On April 1, 2024, the Reporting Person and the Issuer entered into an agreement whereby the Reporting Person elected to be paid part of his salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025.

On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's fees as a Board Director in stock options in lieu of cash compensation. These options vest in twelve (12) monthly installments commencing on April 1, 2024 through April 1, 2025.

On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid for Reporting Person's fees as a Board Director in stock options in lieu of cash compensation. These options vest in twelve (12) monthly installments commencing on April 1, 2024 through April 1, 2025.

On April 1, 2024 the Reporting Person and the Issuer entered into an agreement to elect to be paid part of his salary in stock options in lieu of cash compensation. These options vest in twelve monthly installments commencing on April 1, 2024 through April 1, 2025.

Includes 65,556 Warrants to Purchase Common Stock, and 286,134 Options to Purchase Common Stock.

Includes 1,977 warrants inclusive of 11 warrants acquired in this transaction plus 232,366 stock options.